ELV vs MOH vs CVS Stock Comparison

Elevance Health, Molina Healthcare and Cvs Health Prices as of Nov 13, 2026 Peers: Industry group
ELV Elevance Health, Inc.
$429.67 +0.4% 1M +30.9% 1Y
Market cap
$92.86B
P/E
18.1x
Revenue (TTM)
$201.83B
Div. yield
1.60%
Managed Care Healthcare
1 win
MOH Molina Healthcare, Inc.
$209.62 +0.3% 1M +51.4% 1Y
Market cap
$10.90B
P/E
–
Revenue (TTM)
$44.13B
Div. yield
–
Managed Care Healthcare
2 wins
CVS CVS HEALTH Corp
$89.33 -1.2% 1M +12.7% 1Y
Market cap
$114.34B
P/E
10.4x
Revenue (TTM)
$420.61B
Div. yield
2.99%
Managed Care Healthcare
9 wins

Head to Head

12 decided of 12

Cvs Health leads on 9 of the 12 questions below (Cvs Health 9, Molina Healthcare 2, Elevance Health 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionELVMOHCVSLeader
Larger companyMarket capitalisation $92.86B $10.90B $114.34B CVS
Cheaper on earningsLower P/E, profitable companies only 18.1x -223.6x 10.4x CVS
Cheaper on forward earningsLower price / next fiscal year consensus EPS 14.3x 41.0x 10.2x CVS
Faster revenue growthRevenue growth, trailing twelve months +3.6% -0.9% +6.7% CVS
More profitableNet margin, trailing twelve months 2.5% -0.1% 2.6% CVS
Better return on capitalReturn on invested capital 8.3% 2.2% 9.7% CVS
Less leveragedLower net debt / EBITDA -0.5x -14.4x 2.3x MOH
Higher dividend yieldTrailing dividend yield 1.60% — 2.99% CVS
Better 1-year returnPrice return, last 12 months +30.9% +51.4% +12.7% MOH
Better 5-year returnAnnualised price return, 5 years -0.3%/yr -7.7%/yr -1.0%/yr ELV
Less volatileAnnualised volatility, 1 year 35.6% 52.5% 35.1% CVS
Higher overall scoreMean of the five percentile scores vs peers 68/100 36/100 72/100 CVS

Percentile Scorecard

ELVMOHCVS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisELVMOHCVS
Valuation 81 #6 of 27 42 #16 of 27 100 #1 of 27
Growth 36 #17 of 26 4 #25 of 26 80 #6 of 26
Profitability 72 #8 of 26 32 #18 of 26 84 #5 of 26
Financial Health 68 #9 of 26 64 #10 of 26 24 #20 of 26
Shareholder Returns 82 #4 of 18 – 71 #6 of 18
Overall 68 36 72
  • ELV ranked among 27 companies in Healthcare Payers and Distributors
  • MOH ranked among 27 companies in Healthcare Payers and Distributors
  • CVS ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodELVMOHCVSSPY
1 month +0.4%+0.3%-1.2% -2.0%
3 months +7.3%-1.3%-8.1% -2.8%
6 months +9.4%+13.3%-6.8% +2.0%
Year to date +22.6%+20.8%+12.6% +10.6%
1 year +30.9%+51.4%+12.7% +12.2%
3 years -6.9%-42.2%+30.4% +68.1%
3 years, per year -2.4%-16.7%+9.3% +18.9%
5 years -1.7%-33.1%-5.0% +61.4%
5 years, per year -0.3%-7.7%-1.0% +10.1%
10 years +221.4%+341.0%+19.0% +248.5%
10 years, per year +12.4%+16.0%+1.8% +13.3%

Risk

MeasureELVMOHCVSSPY
Volatility, 1Y 35.6%52.5%35.1% 13.6%
Downside volatility, 1Y 38.1%57.9%38.8% 13.9%
Beta vs S&P 500, 1Y 0.29-0.01-0.05 1.00
Return / volatility, 1Y 0.870.980.36 0.90
Max drawdown, 5Y -51.2%-70.8%-60.5% -25.4%
From 52-week high -3.5%-13.7%-19.2% -3.2%
52-week high $445.45$242.88$110.55 $779.14
52-week low $280.74$122.65$70.08 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleELVMOHCVS
P/E now vs peer median 18.1xmedian 25.2x -223.6xmedian 25.2x 10.4xmedian 25.2x
P/S now vs peer median 0.5xmedian 0.4x 0.2xmedian 0.4x 0.3xmedian 0.4x
EV/EBITDA now vs peer median 9.6xmedian 14.5x 18.3xmedian 14.5x 8.2xmedian 14.5x
P/FCF now vs peer median 14.3xmedian 16.5x 45.8xmedian 16.5x 7.3xmedian 16.5x
P/B now vs peer median 2.1xmedian 2.7x 2.6xmedian 2.7x 1.4xmedian 2.7x
PEG now vs peer median -7.75median 1.72 8.22median 1.72 1.22median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsELVMOHCVS
Revenue $201.83B $44.13B $420.61B
Gross profit $53.35B $5.56B $186.06B
Operating income $7.70B $172.00M $15.06B
Net income $5.13B -$48.00M $11.09B
Free cash flow $6.51B $238.00M $15.57B
EPS (diluted) $23.62 $-0.93 $8.55
Cash & equivalents $10.35B $4.48B $11.74B
Total debt $30.76B $3.77B $60.68B
Shares (diluted) 217.60M 51.50M 1.29B
Enterprise value -$49.61B -$24.10B $63.29B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricELVMOHCVS
P/E 18.1x -223.6x 10.4x
P/FCF 14.3x 45.8x 7.3x
P/Operating cash flow 12.2x 32.9x 6.1x
P/S 0.5x 0.2x 0.3x
P/B 2.1x 2.6x 1.4x
P/Tangible book 2.7x 2.6x 2.0x
EV/EBITDA 9.6x 18.3x 8.2x
EV/EBIT 11.4x 35.4x 10.6x
EV/Revenue 0.4x 0.1x 0.4x
EV/FCF 13.5x 25.6x 10.3x
EV/Operating cash flow 11.6x 18.4x 8.6x
PEG (3Y EPS CAGR) -7.75 8.22 1.22

Growth

14 metrics
MetricELVMOHCVS
Revenue growth (1Y) 3.6% -0.9% 6.7%
Revenue CAGR (3Y) 6.2% 9.9% 6.5%
Gross profit growth (1Y) 4.3% -10.2% 5.3%
Gross profit CAGR (3Y) 5.5% 3.3% 10.9%
Operating income growth (1Y) -9.2% -87.0% 206.4%
Operating income CAGR (3Y) -4.2% -49.8% 2.4%
Net income growth (1Y) -7.4% -105.4% 2,369%
Net income CAGR (3Y) -5.2% -27.1% 8.6%
EPS growth (1Y) -4.5% -105.5% 2,213%
EPS CAGR (3Y) -2.3% -27.2% 8.5%
Operating cash flow growth (1Y) 54.6% 171.8% 105.4%
Operating cash flow CAGR (3Y) -7.2% -46.3% 9.9%
Free cash flow growth (1Y) 72.9% 141.5% 147.4%
Free cash flow CAGR (3Y) -7.6% -51.1% 11.3%

Profitability

14 metrics
MetricELVMOHCVS
Gross margin 26.4% 12.6% 44.2%
EBITDA margin 4.6% 0.8% 4.7%
Operating margin 3.8% 0.4% 3.6%
Pretax margin 3.1% -0.1% 2.9%
Net margin 2.5% -0.1% 2.6%
FCF margin 3.2% 0.5% 3.7%
Operating cash flow margin 3.8% 0.8% 4.4%
Return on equity 11.4% -1.2% 13.8%
Return on assets 4.0% -0.3% 4.3%
Return on invested capital 8.3% 2.2% 9.7%
Return on capital employed 9.6% 2.0% 9.2%
Asset turnover 1.6x 2.8x 1.6x
Cash conversion (OCF / net income) 1.5x -6.9x 1.7x
Stock comp / revenue 0.1% 0.2% 0.2%

Financial Health

11 metrics
MetricELVMOHCVS
Debt / assets 24.1% 24.1% 23.5%
Debt / equity 0.7x 0.9x 0.8x
Net debt / EBITDA -0.5x -14.4x 2.3x
Debt / FCF 4.7x 15.8x 3.9x
Liabilities / assets 65.0% 73.5% 68.7%
Equity / assets 35.0% 26.5% 31.3%
Interest coverage 5.3x 0.8x 4.9x
Current ratio 1.5x 1.7x 0.9x
Quick ratio 1.2x 1.6x 0.8x
Cash ratio 0.8x 1.2x 0.2x
Altman Z-score 3.06 4.15 2.51

Shareholder Returns

7 metrics
MetricELVMOHCVS
Dividend yield 1.6% – 3.0%
Net buyback yield 2.2% – -0.4%
Shareholder yield 3.8% – 2.6%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusELVMOHCVS
Forward P/E 14.3xFY2026 41.0xFY2026 10.2xFY2026
EPS, next fiscal year $30.12FY2026 $5.11FY2026 $8.80FY2026
EPS growth, next FY -0.6%FY2026 -53.7%FY2026 +30.4%FY2026
EPS growth, the year after +4.2% +93.0% +1.1%
Revenue, next fiscal year $211.92BFY2026 $41.59BFY2026 $431.16BFY2026
Revenue growth, next FY +7.3%FY2026 -8.5%FY2026 +7.2%FY2026
Revenue growth, the year after +0.0% +20.4% -5.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersELVMOHCVS
Held by institutions 91.8% 100.0% 89.1%
Institutions holding 1,615 600 2,074
Change in shares held, QoQ +1.7% +1.2% +3.5%
Institutions buying 862 364 1,103
Institutions selling 542 170 733
Buyers to sellers 1.59 2.14 1.50

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ELVMOHCVS
ELV 1.00 0.46 0.42
MOH 0.46 1.00 0.21
CVS 0.42 0.21 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ELV, MOH and CVS?

Cvs Health (CVS) is the largest by market capitalisation: Elevance Health (ELV) $92.86B, Molina Healthcare (MOH) $10.90B, Cvs Health (CVS) $114.34B.

Which stock is cheaper, ELV, MOH and CVS?

Cvs Health (CVS) trades on the lowest price-to-earnings ratio (Elevance Health (ELV) 18.1x, Molina Healthcare (MOH) -223.6x, Cvs Health (CVS) 10.4x). On next year's consensus earnings, Cvs Health (CVS) is cheapest (Elevance Health (ELV) 14.3x, Molina Healthcare (MOH) 41.0x, Cvs Health (CVS) 10.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Cvs Health (CVS) grew revenue fastest over the trailing twelve months: Elevance Health (ELV) +3.6%, Molina Healthcare (MOH) -0.9%, Cvs Health (CVS) +6.7%.

Which company is more profitable?

Cvs Health (CVS) has the highest net margin (Elevance Health (ELV) 2.5%, Molina Healthcare (MOH) -0.1%, Cvs Health (CVS) 2.6%). On return on invested capital, Cvs Health (CVS) leads (Elevance Health (ELV) 8.3%, Molina Healthcare (MOH) 2.2%, Cvs Health (CVS) 9.7%).

Which stock has performed better?

Over the past year Molina Healthcare (MOH) returned the most: Elevance Health (ELV) +30.9%, Molina Healthcare (MOH) +51.4%, Cvs Health (CVS) +12.7%. Over five years, Elevance Health (ELV) compounded fastest (Elevance Health (ELV) -0.3%/yr, Molina Healthcare (MOH) -7.7%/yr, Cvs Health (CVS) -1.0%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Cvs Health (CVS) has the highest dividend yield: Elevance Health (ELV) 1.60%, Cvs Health (CVS) 2.99%. Molina Healthcare (MOH) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cvs Health (CVS) has been the steadiest (Elevance Health (ELV) 35.6%, Molina Healthcare (MOH) 52.5%, Cvs Health (CVS) 35.1%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ELV, MOH and CVS?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cvs Health (CVS) leads on 9. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.